Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2023-04-03 Remuneration Information
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Remuneration Information 2023
Remuneration Information Classification · 1% confidence The document is titled 'Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons' and explicitly states it discloses transactions made by managerial employees in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse. This type of filing, reporting personal share transactions by directors and executives (insider trades), directly corresponds to the definition of Director's Dealing (DIRS). Although it is a company announcement, the specific content dictates the classification over a general RPA or RNS.
2023-04-03 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification of a transaction in company shares by a person discharging managerial responsibilities (the CFO, Anthony Pagano). It explicitly references Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which is the standard regulatory framework for reporting insider/director dealings. This fits the definition of 'Director's Dealing' (DIRS).
2023-04-03 English
6-K
Foreign Filer Report
2023-04-03 English
Regulatory Filings 2023
Regulatory Filings Classification · 1% confidence The document text consists almost entirely of tabular data showing trade volumes, prices, venue (XCSE - Nasdaq Stockholm), and timestamps (Time CET). The content strongly suggests real-time or near real-time market activity data, likely related to stock transactions or order book updates. This type of data is typically disseminated via regulatory feeds or specific market data services. Reviewing the provided filing types, none perfectly match raw trade data dumps. However, the presence of codes like '1' (Volume), '17' (Price), '14' (Venue), and '10' (Time) within the table structure, alongside other numerical codes that might represent transaction types or identifiers, suggests this is a structured data report. Given the options, this is most likely supplementary data provided in a machine-readable format, which aligns best with 'Financial Supplement Data (XLSX)', even though the format here is text-based tabular data rather than an actual Excel file. Since it is structured data, and not a narrative report, 'XLSX' is the closest fit for detailed, structured data dissemination. If this were a regulatory filing announcing a transaction, it might fit 'DIRS' or 'MRQ', but the sheer volume of granular trade data points towards a data supplement.
2023-04-03 English
Completion of share buy-back program
Transaction in Own Shares Classification · 1% confidence The document is a formal company announcement from Genmab regarding the completion of a share buy-back program. It details the number of shares repurchased, the average price, and the total value, and confirms that the program has concluded. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2023-04-03 English
Completion of share buy-back program
Transaction in Own Shares Classification · 1% confidence The document is a company announcement detailing the completion of a share buy-back program. It provides specific transaction data, the total number of shares repurchased, and the total cost. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2023-04-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.